Company Profile

Lavax Inc (AKA: Lin Tao)
Profile last edited on: 7/21/15      CAGE: 48Y62      UEI:

Business Identifier: probiotics research for medical applications
Year Founded
1999
First Award
2007
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1265 North Wellington Drive
Palatine, IL 60067
   (847) 776-2435
   renjiechang@aol.com
   www.lavaxhealth.com
Location: Single
Congr. District: 06
County: Cook

Public Profile

Lavax Inc is a small company whose primary focus is on probiotics research for medical applications. Lavax investigates applications in sexual health and fighting infectious diseases, and cancer. Lavax is developing and testing a vaginal suppository that uses a strain of commensal bacteria which has the ability to immobilize sperm and capture viruses. If successful, the bacteria could be used as a reversible contraceptive that also affords protection against viruses such as HIV and herpes. Lavax has developed a natural food substance that reduces HIV viruses in the mother’s milk, and will test it along with scientists at University of Toledo for its ability to block HIV transmission from mothers to infants

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 1 NIH $254,578
Project Title: A Novel High-Efficiency Transfection Technology
2008 2 NIH $358,260
Project Title: A Probiotic Formula Protects Infants from Milk-Borne HIV Transmission

Key People / Management

  Lin Tao -- President

  Renjie Chang

Company News

There are no news available.